CVnCoV mRNA vaccine; SARS-CoV-2; COVID-19; adults; randomised clinical trial
Ivermectin, Plasmodium falciparum, Blood stages, In vitro activity, In vivo efficacy, Dose-escalation, Randomized, Double-blind, safety, Adverse events, Parasite reduction, Transmission, Antiparasitic effect, Lambaréné, Gabon, Parasite load reduction, Tolerability, Mosquitocidal effect
Gut microbiome, microbial-induced lactose tolerance, lactose intolerance, lactase non-persistence, diet, hydrogen sulfide, methane, gas exhalation, lactulose